Sorafenib is effective for imatinib-resistant FIP1L1/PDGFRA T674I mutation-positive acute myeloid leukemia with eosinophilia

Arwa Z. Al-Riyami; Monika Hudoba; Sean Young; Donna Forrest

doi:10.3109/10428194.2012.749469

Sorafenib is effective for imatinib-resistant FIP1L1/PDGFRA T674I mutation-positive acute myeloid leukemia with eosinophilia

Arwa Z. Al-Riyami, Monika Hudoba, Sean Young, Donna Forrest^*

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

7 Citations (Scopus)

Original language	English
Pages (from-to)	1788-1790
Number of pages	3
Journal	Leukemia and Lymphoma
Volume	54
Issue number	8
DOIs	https://doi.org/10.3109/10428194.2012.749469
Publication status	Published - Aug 2013
Externally published	Yes

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.3109/10428194.2012.749469

Cite this

@article{8b09baa4440b40fc84d9fdc019d772fa,

title = "Sorafenib is effective for imatinib-resistant FIP1L1/PDGFRA T674I mutation-positive acute myeloid leukemia with eosinophilia",

author = "Al-Riyami, {Arwa Z.} and Monika Hudoba and Sean Young and Donna Forrest",

year = "2013",

month = aug,

doi = "10.3109/10428194.2012.749469",

language = "English",

volume = "54",

pages = "1788--1790",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "8",

}

TY - JOUR

T1 - Sorafenib is effective for imatinib-resistant FIP1L1/PDGFRA T674I mutation-positive acute myeloid leukemia with eosinophilia

AU - Al-Riyami, Arwa Z.

AU - Hudoba, Monika

AU - Young, Sean

AU - Forrest, Donna

PY - 2013/8

Y1 - 2013/8

UR - http://www.scopus.com/inward/record.url?scp=84880291638&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880291638&partnerID=8YFLogxK

U2 - 10.3109/10428194.2012.749469

DO - 10.3109/10428194.2012.749469

M3 - Letter

C2 - 23157309

AN - SCOPUS:84880291638

SN - 1042-8194

VL - 54

SP - 1788

EP - 1790

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 8

ER -

Sorafenib is effective for imatinib-resistant FIP1L1/PDGFRA T674I mutation-positive acute myeloid leukemia with eosinophilia

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this